AI in clinical trials: The gap between promise and reality
AI is transforming clinical trials by accelerating patient enrollment, reducing delays, and improving trial operations. Explore how AI and clinical trials consulting can drive faster, more efficient clinical development.
managementconsulting849 Clinical trials have always been slow, with patient enrollment alone taking 1.8 times longer than planned in roughly 85% of trials. Every day a trial is delayed costs somewhere between $600,000 and $8 million in lost revenue. That is not a rounding error. That is a crisis hiding in plain sight.
Artificial intelligence (AI) offers a great way to overcome these challenges. While it is not a magic fix, it is definitely the most credible answer the industry has found so far. Many organizations are also turning to clinical trials consulting experts to develop AI adoption strategies, improve trial operations, and address implementation challenges across the clinical development lifecycle.
Barriers to AI integration in clinical trials
The potential of AI is real, but so are the roadblocks. Here are some of the barriers to successful AI integration in clinical trials:
-
Data access and quality: Healthcare data is often hard to get, poorly structured, and full of gaps. Without fixing this, AI tools cannot perform reliably no matter how good the underlying model is.
-
Internal data maturity: Most companies already sit on valuable internal data. The problem is it is rarely organized or accessible enough to be useful for AI applications.
-
Data integration: Combining data from different sources in a smooth and standardized way will help AI work better. However, that requires IT support to connect these data sources properly and ensure everything works together.
-
Skill gaps: There are simply not enough people who understand both data science and clinical development. Existing roles will need to evolve, and new ones will need to be created.
-
Scalability: AI tools that work well in a pilot often struggle when applied at scale. This has to be planned for from day one, not figured out after the fact.
Learning from other industries
As the pharmaceutical industry continues to slowly integrate AI into its clinical trial process, it can definitely learn a lot from other industries that have already integrated AI successfully. For instance, the tech sector has great experience managing unstructured and missing data, which can help solve similar issues in clinical trials. Similarly, the professionals from finance and ecommerce, where data science is widely used, can help address the current shortage of skilled professionals in pharma.
Companies in these spaces also have a head start on building the kind of customer experience solution infrastructure that helps teams make faster, smarter decisions using real-time data, something clinical operations teams are only beginning to adopt.
The road ahead
Getting AI to work in clinical trials is not just a technology problem. It is a data problem, a talent problem and a change management problem all at once. Navigating these challenges requires more than technology alone. This is where working with the right clinical trials consulting partner makes a practical difference. They bring together the clinical expertise, data strategy and change management support that most organizations cannot build internally fast enough to stay competitive.
Overall, AI has the potential to make trials faster, cheaper and more patient-focused. The organizations that get there first will be the ones that treat it as a strategic priority, not just a technology experiment.
